共 17 条
- [1] [Anonymous], 2002, GUID IND FOOD EFF BI
- [2] [Anonymous], EUR J CANC S
- [3] AstraZeneca, 2015, GLOB POL BIOETH
- [4] Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial[J]. LANCET, 2010, 376 (9737) : 245 - 251Audeh, M. William论文数: 0 引用数: 0 h-index: 0机构: Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USA Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USACarmichael, James论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAPenson, Richard T.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Dana Farber Canc Inst, Boston, MA 02115 USA Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAFriedlander, Michael论文数: 0 引用数: 0 h-index: 0机构: Prince Wales Canc Ctr, Sydney, NSW, Australia Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAPowell, Bethan论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USABell-McGuinn, Katherine M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAScott, Clare论文数: 0 引用数: 0 h-index: 0机构: Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia Royal Melbourne Hosp, Melbourne, Vic, Australia Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAWeitzel, Jeffrey N.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Duarte, CA USA Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAOaknin, Ana论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Valle Hebron, Barcelona, Spain Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USALoman, Niklas论文数: 0 引用数: 0 h-index: 0机构: Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USALu, Karen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USASchmutzler, Rita K.论文数: 0 引用数: 0 h-index: 0机构: Univ Cologne, Ctr Familial Breast, Cologne, Germany Univ Cologne, Ovarian Canc, Cologne, Germany Univ Cologne, Ctr Integrated Oncol, Cologne, Germany Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAMatulonis, Ursula论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Dana Farber Canc Inst, Boston, MA 02115 USA Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USAWickens, Mark论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USATutt, Andrew论文数: 0 引用数: 0 h-index: 0机构: Kings Coll London, Breakthrough Breast Canc Res Unit, Sch Med, London WC2R 2LS, England Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USA
- [5] Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin[J]. CLINICAL CANCER RESEARCH, 2008, 14 (12) : 3916 - 3925Evers, Bastiaan论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsDrost, Rinske论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsSchut, Eva论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlandsde Bruin, Michiel论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlandsvan der Burg, Eline论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsDerksen, Patrick W. B.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsHolstege, Henne论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsLiu, Xiaoling论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlandsvan Drunen, Ellen论文数: 0 引用数: 0 h-index: 0机构: Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsBeverloo, H. Berna论文数: 0 引用数: 0 h-index: 0机构: Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsSmith, Graeme C. M.论文数: 0 引用数: 0 h-index: 0机构: KuDOS Pharmaceut Ltd, Cambridge, England Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsMartin, Niall M. B.论文数: 0 引用数: 0 h-index: 0机构: KuDOS Pharmaceut Ltd, Cambridge, England Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsLau, Alan论文数: 0 引用数: 0 h-index: 0机构: KuDOS Pharmaceut Ltd, Cambridge, England Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsO'Connor, Mark J.论文数: 0 引用数: 0 h-index: 0机构: KuDOS Pharmaceut Ltd, Cambridge, England Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, NetherlandsJonkers, Jos论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands
- [6] Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) : 123 - 134Fong, Peter C.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandBoss, David S.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Amsterdam, Netherlands Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandYap, Timothy A.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandTutt, Andrew论文数: 0 引用数: 0 h-index: 0机构: Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandWu, Peijun论文数: 0 引用数: 0 h-index: 0机构: Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England KuDOS Pharmaceut, Cambridge, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandMergui-Roelvink, Marja论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Amsterdam, Netherlands Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandMortimer, Peter论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandSwaisland, Helen论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandLau, Alan论文数: 0 引用数: 0 h-index: 0机构: KuDOS Pharmaceut, Cambridge, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandO'Connor, Mark J.论文数: 0 引用数: 0 h-index: 0机构: KuDOS Pharmaceut, Cambridge, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandAshworth, Alan论文数: 0 引用数: 0 h-index: 0机构: Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandCarmichael, James论文数: 0 引用数: 0 h-index: 0机构: KuDOS Pharmaceut, Cambridge, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandKaye, Stan B.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, EnglandSchellens, Jan H. M.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Amsterdam, Netherlands Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, Englandde Bono, Johann S.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England
- [7] Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study[J]. LANCET ONCOLOGY, 2011, 12 (09) : 852 - 861Gelmon, Karen A.论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaTischkowitz, Marc论文数: 0 引用数: 0 h-index: 0机构: McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaMackay, Helen论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaSwenerton, Kenneth论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaRobidoux, Andre论文数: 0 引用数: 0 h-index: 0机构: Univ Montreal Hotel Dieu, Ctr Hosp, Montreal, PQ, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaTonkin, Katia论文数: 0 引用数: 0 h-index: 0机构: Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaHirte, Hal论文数: 0 引用数: 0 h-index: 0机构: Juravinski Canc Ctr, Hamilton, ON, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaHuntsman, David论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaClemons, Mark论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaGilks, Blake论文数: 0 引用数: 0 h-index: 0机构: Univ British Columbia, Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaYerushalmi, Rinat论文数: 0 引用数: 0 h-index: 0机构: British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaMacpherson, Euan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaCarmichael, James论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, CanadaOza, Amit论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
- [8] Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 244 - 250Kaufman, Bella论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Tel Hashomer, Israel Sheba Med Ctr, Tel Hashomer, IsraelShapira-Frommer, Ronnie论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Tel Hashomer, Israel Sheba Med Ctr, Tel Hashomer, IsraelSchmutzler, Rita K.论文数: 0 引用数: 0 h-index: 0机构: Ctr Familial Breast & Ovarian Canc, Cologne, Germany Ctr Integrated Oncol, Cologne, Germany Sheba Med Ctr, Tel Hashomer, IsraelAudeh, M. William论文数: 0 引用数: 0 h-index: 0机构: Samuel Oschin Canc Inst, Los Angeles, CA USA Sheba Med Ctr, Tel Hashomer, IsraelFriedlander, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia Sheba Med Ctr, Tel Hashomer, IsraelBalmana, Judith论文数: 0 引用数: 0 h-index: 0机构: Vall Hebron Inst Oncol, Barcelona, Spain Sheba Med Ctr, Tel Hashomer, IsraelMitchell, Gillian论文数: 0 引用数: 0 h-index: 0机构: Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Sheba Med Ctr, Tel Hashomer, IsraelFried, Georgeta论文数: 0 引用数: 0 h-index: 0机构: Inst Oncol, Jerusalem, Israel Sheba Med Ctr, Tel Hashomer, IsraelStemmer, Salomon M.论文数: 0 引用数: 0 h-index: 0机构: Rabin Med Ctr, Petah Tiqwa, Israel Sheba Med Ctr, Tel Hashomer, IsraelHubert, Ayala论文数: 0 引用数: 0 h-index: 0机构: Hadassah Hebrew Univ Hosp, Sharett Inst Oncol, Jerusalem, Israel Sheba Med Ctr, Tel Hashomer, IsraelRosengarten, Ora论文数: 0 引用数: 0 h-index: 0机构: Shaare Zedek Med Ctr, Jerusalem, Israel Sheba Med Ctr, Tel Hashomer, IsraelSteiner, Mariana论文数: 0 引用数: 0 h-index: 0机构: Linn Med Ctr, Haifa, Israel Sheba Med Ctr, Tel Hashomer, IsraelLoman, Niklas论文数: 0 引用数: 0 h-index: 0机构: Skaones Univ Lund, Lund, Sweden Sheba Med Ctr, Tel Hashomer, IsraelBowen, Karin论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England Sheba Med Ctr, Tel Hashomer, IsraelFielding, Anitra论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England Sheba Med Ctr, Tel Hashomer, IsraelDomchek, Susan M.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Basser Res Ctr, Philadelphia, PA 19104 USA Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Sheba Med Ctr, Tel Hashomer, Israel
- [9] Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial[J]. LANCET ONCOLOGY, 2014, 15 (08) : 852 - 861Ledermann, Jonathan论文数: 0 引用数: 0 h-index: 0机构: UCL, UCL Canc Inst, London W1T 4TJ, England UCL, UCL Canc Inst, London W1T 4TJ, EnglandHarter, Philipp论文数: 0 引用数: 0 h-index: 0机构: Kliniken Essen Mitte, Essen, Germany UCL, UCL Canc Inst, London W1T 4TJ, EnglandGourley, Charlie论文数: 0 引用数: 0 h-index: 0机构: Univ Edinburgh, Canc Res UK Ctr, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland UCL, UCL Canc Inst, London W1T 4TJ, EnglandFriedlander, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ New S Wales, Prince Wales Clin Sch, Randwick, NSW, Australia UCL, UCL Canc Inst, London W1T 4TJ, EnglandVergote, Ignace论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven, Leuven, Belgium UCL, UCL Canc Inst, London W1T 4TJ, EnglandRustin, Gordon论文数: 0 引用数: 0 h-index: 0机构: Mt Vernon Hosp, Northwood HA6 2RN, Middx, England UCL, UCL Canc Inst, London W1T 4TJ, EnglandScott, Clare L.论文数: 0 引用数: 0 h-index: 0机构: Royal Melbourne Hosp, Parkville, NSW, Australia UCL, UCL Canc Inst, London W1T 4TJ, EnglandMeier, Werner论文数: 0 引用数: 0 h-index: 0机构: Evangel Krankenhaus, Dusseldorf, Germany UCL, UCL Canc Inst, London W1T 4TJ, EnglandShapira-Frommer, Ronnie论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel UCL, UCL Canc Inst, London W1T 4TJ, EnglandSafra, Tamar论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel UCL, UCL Canc Inst, London W1T 4TJ, EnglandMatei, Daniela论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ Sch Med, Indianapolis, IN 46202 USA UCL, UCL Canc Inst, London W1T 4TJ, EnglandFielding, Anitra论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England UCL, UCL Canc Inst, London W1T 4TJ, EnglandSpencer, Stuart论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England UCL, UCL Canc Inst, London W1T 4TJ, EnglandDougherty, Brian论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Waltham, MA USA UCL, UCL Canc Inst, London W1T 4TJ, EnglandOrr, Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England UCL, UCL Canc Inst, London W1T 4TJ, EnglandHodgson, Darren论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England UCL, UCL Canc Inst, London W1T 4TJ, EnglandBarrett, J. Carl论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Waltham, MA USA UCL, UCL Canc Inst, London W1T 4TJ, EnglandMatulonis, Ursula论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA UCL, UCL Canc Inst, London W1T 4TJ, England
- [10] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15) : 1382 - 1392Ledermann, Jonathan论文数: 0 引用数: 0 h-index: 0机构: UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, England UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandHarter, Philipp论文数: 0 引用数: 0 h-index: 0机构: Kliniken Essen Mitte, Essen, Germany UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandGourley, Charlie论文数: 0 引用数: 0 h-index: 0机构: Univ Edinburgh, Canc Res UK Ctr, Edinburgh, Midlothian, Scotland UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandFriedlander, Michael论文数: 0 引用数: 0 h-index: 0机构: Prince Wales Hosp, Randwick, NSW 2031, Australia UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandVergote, Ignace论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Louvain, Belgium UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandRustin, Gordon论文数: 0 引用数: 0 h-index: 0机构: Mt Vernon Hosp, Northwood HA6 2RN, Middx, England UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandScott, Clare论文数: 0 引用数: 0 h-index: 0机构: Royal Melbourne Hosp, Parkville, Vic 3050, Australia UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandMeier, Werner论文数: 0 引用数: 0 h-index: 0机构: Evangel Krankenhaus, Dusseldorf, Germany UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandShapira-Frommer, Ronnie论文数: 0 引用数: 0 h-index: 0机构: Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandSafra, Tamar论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandMatei, Daniela论文数: 0 引用数: 0 h-index: 0机构: Indiana Univ Sch Med, Indianapolis, IN USA UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandMacpherson, Euan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandWatkins, Claire论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandCarmichael, James论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, EnglandMatulonis, Ursula论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA UCL, Inst Canc, UCL & UCL Hosp Comprehens Biomed Res Ctr, London W1T 4TJ, England